Immediate Impact

1 from Science/Nature 70 standout
Sub-graph 1 of 24

Citing Papers

Traditional Chinese medicine in lung cancer treatment
2025 Standout
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer
2025 Standout
2 intermediate papers

Works of Manoj Chiney being referenced

Phase 1, first-in-human study of TRAIL receptor agonist fusion protein ABBV-621.
2019
Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin
2017

Author Peers

Author Last Decade Papers Cites
Manoj Chiney 44 37 10 23 11 129
Julie K. Rhie 53 76 9 16 11 204
Ariel M. Ley 69 39 9 8 9 180
Guillaume Becker 59 40 5 32 18 186
Mingqing Chen 38 93 18 9 11 187
Sharmila Rajan 67 41 15 14 11 171
Zeina N. Al-Mahayri 46 49 5 7 16 207
Dilana E. Staudt 60 43 3 28 8 183
Nico van de Merbel 57 29 5 9 10 242
JoAl Mayor 30 74 3 12 17 120
A. Doria 74 43 7 16 20 199

All Works

Loading papers...

Rankless by CCL
2026